Mangalam Drugs & Organics Limited (BOM:532637)

India flag India · Delayed Price · Currency is INR
28.91
+0.56 (1.98%)
At close: Apr 28, 2026
-63.64%
Market Cap 457.59M
Revenue (ttm) 2.38B
Net Income (ttm) -309.21M
Shares Out 15.83M
EPS (ttm) -19.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,614
Average Volume 4,712
Open 28.91
Previous Close 28.35
Day's Range 28.91 - 28.91
52-Week Range 22.70 - 94.80
Beta 0.10
RSI 48.76
Earnings Date May 30, 2026

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaqui... [Read more]

Industry Pharmaceutical Preparations
Founded 1972
Employees 480
Stock Exchange Bombay Stock Exchange
Ticker Symbol 532637
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.